Connor, Clark & Lunn Investment Management (CC&L)
HCAT icon

Connor, Clark & Lunn Investment Management (CC&L)’s Health Catalyst HCAT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-581,361
Closed -$1.39M – 1651
2025
Q4 		$1.39M Sell
581,361
-389,328
-40% -$1.06M ﹤0.01% 1029
2025
Q3 		$2.77M Sell
970,689
-95,707
-9% -$328K 0.01% 752
2025
Q2 		$4.02M Buy
1,066,396
+372,035
+54% +$1.46M 0.01% 644
2025
Q1 		$3.15M Buy
694,361
+439,599
+173% +$2.33M 0.01% 610
2024
Q4 		$1.8M Buy
254,762
+123,230
+94% +$981K 0.01% 757
2024
Q3 		$1.07M Buy
131,532
+71,201
+118% +$515K 0.01% 864
2024
Q2 		$386K Sell
60,331
-10,631
-15% -$68.2K ﹤0.01% 1117
2024
Q1 		$534K Buy
70,962
+12,545
+21% +$115K ﹤0.01% 1086
2023
Q4 		$541K Buy
+58,417
New +$477K ﹤0.01% 1024
2023
Q2 		– Sell
-15,433
Closed -$180K – 1388
2023
Q1 		$180K Sell
15,433
-69,443
-82% -$885K ﹤0.01% 1110
2022
Q4 		$902K Sell
84,876
-56,450
-40% -$545K 0.01% 730
2022
Q3 		$1.37M Sell
141,326
-18,798
-12% -$249K 0.01% 582
2022
Q2 		$2.32M Buy
160,124
+149,001
+1,340% +$2.54M 0.01% 446
2022
Q1 		$291K Buy
+11,123
New +$316K ﹤0.01% 882

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s HCAT Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 581,361 shares — an estimated $1.39M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HCAT in Q1 2022 and held it in 14 quarters. The position peaked at $4.02M in Q2 2025. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 581,361 Health Catalyst shares in Q1 2026, an estimated $1.39M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Health Catalyst in Q1 2022 and held it in 14 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Health Catalyst position peaked at $4.02M in Q2 2025.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.